A research paper published in the American Heart Association has backed the decision of the National Pharmaceutical Pricing Authority to slash prices of stents in India by 85 per cent. The research paper — India and the Coronary Stent Market-Getting the Price Right — views this as a corrective measure. It says stent prices in India are higher than in the US.
While prices of drug-eluting stents vary between $600 and $2,971 in India, it is sold at around $1,200 in the US, it noted.
The report believes NPPA’s decision would also benefit domestic stent makers. “Foreign firms
While prices of drug-eluting stents vary between $600 and $2,971 in India, it is sold at around $1,200 in the US, it noted.
The report believes NPPA’s decision would also benefit domestic stent makers. “Foreign firms

)